(#11 of 18): Why focus on pharmacy revenue cycle?
#11: Why focus on pharmacy revenue cycle? Join Joe Cesarz, Vice President, Hospitals & Health Systems, as he discusses why it is important to focus on the pharmacy revenue cycle to uncover opportunities for financial growth.
(#10 of 18): What are Visante’s strategies for 340B optimization?
#10: What are Visante’s strategies for 340B optimization? Join Justin Ott, Vice President, 340B ACE, and Jerame Hill, Vice President, as they discuss Visante’s strategies for 340B optimization that include program expansion, e-prescribing, and more.
(#9 of 18): Does Visante provide ongoing routine oversight for 340B programs?
#9: Does Visante provide ongoing routine oversight for 340B programs? Join Kristin Fox-Smith, Senior Vice President, Hospital & Health System Services, 340B ACE, as she discusses Visante’s ongoing routine oversight support services for newly eligible covered entities.
(#8 of 18): Why should a covered entity partner with Visante for their 340B program audits?
#8: Why should a covered entity partner with Visante for their 340B program audits? Join Kristin Fox-Smith, Senior Vice President, Hospital & Health System Services, 340B ACE, as she discusses why a covered entity should partner with Visante for 340B program audits.
(#7 of 18): What is Pharmacy Performance Solutions, and why should hospitals be interested in this now?
#7: What is Pharmacy Performance Solutions, and why should hospitals be interested in this now? Join Steve Rough, Senior Vice President, and Kristin Fox-Smith, Senior Vice President, Hospital & Health System Services, 340B ACE, as they discuss what Pharmacy Performance Solutions is and how hospitals and health systems can benefit.
(#6 of 18): What are some of the common mistakes that systems make pertaining to pharmacy leadership?
#6: What are some of the common mistakes that systems make pertaining to pharmacy leadership? Join Jim Jorgenson, CEO, and Steve Rough, Senior Vice President, as they discuss some of the common mistakes in pharmacy leadership.
(#5 of 18): Why is there sometimes resistance to structuring pharmacy for optimal success?
#5: Why is there sometimes resistance to structuring pharmacy for optimal success? Join Jim Jorgenson, CEO, and Steve Rough, Senior Vice President, as they discuss one of the major points of resistance to a new pharmacy organizational structure.
(#4 of 18): What structure seems to work best when reconfiguring leadership teams to improve organizational performance?
#4: What structure seems to work best when reconfiguring leadership teams to improve organizational performance? Join Jim Jorgenson, CEO, and Steve Rough, Senior Vice President, as they discuss how the application of a business within a business philosophy works best when organizing the pharmacy service line.
(#3 of 18): Why are leading health systems reconfiguring their leadership teams to improve organizational performance?
#3: Why are leading health systems reconfiguring their leadership teams to improve organizational performance? Join Jim Jorgenson, CEO, and Steve Rough, Senior Vice President, as they discuss why health systems are reconfiguring their leadership teams to improve quality of care and financial management.
(#2 of 18): How can hospitals and health systems make the most of the strategic asset of pharmacy?
#2: How can hospitals and health systems make the most of the strategic asset of pharmacy? Join Jim Jorgenson, CEO, as he discusses how Visante works with clients to unlock a comprehensive assessment of its pharmacy services with eight questions or areas of inquiry.
